Glaukos Corporation (GKOS) Covered Calls

You can sell covered calls on Glaukos Corporation to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for GKOS (prices last updated Fri 4:16 PM ET):

Glaukos Corporation (GKOS) Stock Quote
Last	Change	Bid	Ask	Volume	P/E	Market Cap
138.44	-0.18	134.00	143.94	337K	-	7.6

Covered Calls For Glaukos Corporation (GKOS)
Expiration	Strike	Call Bid	Net Debit	Return If Flat	Annualized Return If Flat
Dec 20	140	5.40	138.54	1.1%	11.2%
Jan 17	140	7.50	136.44	2.6%	14.8%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls? Sign Up For A Free Trial

Extended Business Description

Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development and commercialization of surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Inject trabecular micro-bypass stent that allows the surgeon to inject stents into various trabecular meshwork locations through a single corneal entry; iStent Supra suprachoroidal micro-bypass stent, which is designed to reduce intraocular pressure by accessing the suprachoroidal space in the eye; and iDose, a targeted injectable drug delivery implant that is designed to be pre-loaded into a small gauge needle and injected into the eye through a self-sealing corneal needle penetration. Its product pipeline also consists of iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure; and iStent Infinite trabecular micro-bypass system, which is used as a standalone procedure in patients with refractory glaucoma. Glaukos Corporation markets its products through direct sales force in the United States and internationally, as well as through distribution partners in Europe, the Asia Pacific, Latin America, and internationally. The company was founded in 1998 and is headquartered in San Clemente, California.

Top 10 Open Interest For Dec 20 Expiration				Top 5 High Yield
1.	NVDA covered calls	6.	QQQ covered calls	1.	SAVA covered calls
2.	SPY covered calls	7.	XLF covered calls	2.	RKLB covered calls
3.	EEM covered calls	8.	KWEB covered calls	3.	LUNR covered calls
4.	FXI covered calls	9.	TLT covered calls	4.	NMRA covered calls
5.	IWM covered calls	10.	KRE covered calls	5.	CRVS covered calls

Want more examples? GK Covered Calls | GL Covered Calls